|Bid||5.25 x 800|
|Ask||5.44 x 800|
|Day's range||5.22 - 5.40|
|52-week range||2.91 - 12.50|
|Beta (5Y monthly)||1.50|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Ocular Therapeutix (OCUL) delivered earnings and revenue surprises of -21.74% and 11.18%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
If you want to know who really controls Ocular Therapeutix, Inc. ( NASDAQ:OCUL ), then you'll have to look at the...
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...